Cargando…
Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach
The lung cancer stem cell (LuCSC) model comprises an attractive framework to explore acquired drug resistance in non-small cell lung cancer (NSCLC) treatment. Here, we used NSCLC cell line model to translate cellular heterogeneity into tractable populations to understand the origin of lung cancers a...
Autores principales: | Xiao, Zhiguang, Sperl, Bianca, Gärtner, Silvia, Nedelko, Tatiana, Stacher-Priehse, Elvira, Ullrich, Axel, Knyazev, Pjotr G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493460/ https://www.ncbi.nlm.nih.gov/pubmed/31069016 http://dx.doi.org/10.18632/oncotarget.26817 |
Ejemplares similares
-
Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach
por: Xiao, Zhiguang, et al.
Publicado: (2021) -
Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
por: Xiao, Zhiguang, et al.
Publicado: (2014) -
Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients
por: Xiao, Zhiguang, et al.
Publicado: (2017) -
Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines
por: Gusenbauer, Simone, et al.
Publicado: (2015) -
Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis
por: Popper, Helmut, et al.
Publicado: (2021)